Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneet Dewan

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
BMJ Global Health|December 30, 2020
Field sales force model to increase adoption of a novel tuberculosis diagnostic test among private providers: evidence from IndiaSarang Deo, Pankaj Jindal, Manisha Sabharwal, et al.
Plos One|July 30, 2011
Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic considerationMadhavi Pothukuchi, Sharath Burugina Nagaraja, Santosha Kelamane, et al.
The Lancet. Infectious Diseases|August 29, 2016
The number of privately treated tuberculosis cases in India: an estimation from drug sales dataNimalan Arinaminpathy, Deepak Batra, Sunil Khaparde, et al.
Communications Medicine|July 11, 2022
Making cough count in tuberculosis careAlexandra J Zimmer, César Ugarte-Gil, Rahul Pathri, et al.
Plos One|February 7, 2015
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in IndiaNeeraj Raizada, Kuldeep Singh Sachdeva, Achuthan Sreenivas, et al.
Plos One|February 27, 2016
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective AnalysisSreenivas Achuthan Nair, Neeraj Raizada, Kuldeep Singh Sachdeva, et al.
Scientific Reports|March 9, 2019
Modelling the impact of effective private provider engagement on tuberculosis control in urban IndiaNimalan Arinaminpathy, Sarang Deo, Simrita Singh, et al.
Plos One|March 5, 2015
High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South IndiaN Selvakumar, Vanaja Kumar, S Balaji, et al.
BMJ Global Health|October 6, 2021
Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectivenessNimalan Arinaminpathy, Arindam Nandi, Shibu Vijayan, et al.
Plos One|July 2, 2015
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant TuberculosisKuldeep Singh Sachdeva, Neeraj Raizada, Radhey Shyam Gupta, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
BMJ Global Health|December 30, 2020
Field sales force model to increase adoption of a novel tuberculosis diagnostic test among private providers: evidence from IndiaSarang Deo, Pankaj Jindal, Manisha Sabharwal, et al.
Plos One|July 30, 2011
Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic considerationMadhavi Pothukuchi, Sharath Burugina Nagaraja, Santosha Kelamane, et al.
The Lancet. Infectious Diseases|August 29, 2016
The number of privately treated tuberculosis cases in India: an estimation from drug sales dataNimalan Arinaminpathy, Deepak Batra, Sunil Khaparde, et al.
Communications Medicine|July 11, 2022
Making cough count in tuberculosis careAlexandra J Zimmer, César Ugarte-Gil, Rahul Pathri, et al.
Plos One|February 7, 2015
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in IndiaNeeraj Raizada, Kuldeep Singh Sachdeva, Achuthan Sreenivas, et al.
Plos One|February 27, 2016
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective AnalysisSreenivas Achuthan Nair, Neeraj Raizada, Kuldeep Singh Sachdeva, et al.
Scientific Reports|March 9, 2019
Modelling the impact of effective private provider engagement on tuberculosis control in urban IndiaNimalan Arinaminpathy, Sarang Deo, Simrita Singh, et al.
Plos One|March 5, 2015
High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South IndiaN Selvakumar, Vanaja Kumar, S Balaji, et al.
BMJ Global Health|October 6, 2021
Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectivenessNimalan Arinaminpathy, Arindam Nandi, Shibu Vijayan, et al.
Plos One|July 2, 2015
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant TuberculosisKuldeep Singh Sachdeva, Neeraj Raizada, Radhey Shyam Gupta, et al.
Pageof 4